European Commission President Ursula von der Leyen expects significantly more vaccine doses to be available in the European Union from next month.
“From April onwards, the quantities could double again according to the manufacturers’ plans, also because further vaccines are about to be approved,” she told the Monday editions of local German newspapers the Stuttgarter Zeitung and Stuttgarter Nachrichten in comments seen in advance by dpa.
She expects “an average of around 100 million doses per month in the second quarter, a total of 300 million by the end of June.”
According to the newspapers, this would mean about 20 million doses per month for Germany, which would require significantly higher vaccination capacities.
Since vaccinations began at the end of December, some 7.3 million doses of vaccine have been administered in Germany, according to figures released by the Robert Koch Institute (RKI) for disease control on Friday.
Of almost 5 million people vaccinated, just under half have also received the second vaccination.
So far, the vaccines of the three manufacturers Pfizer/BioNTech, Moderna and AstraZeneca have been approved in the EU.
On Thursday, the European Medicines Agency (EMA) is also expected to recommend approval of the vaccine from the US manufacturer Johnson&Johnson.